MANAGEMENT OF TREATMENT-RESISTANT HYPERTENSION

被引：1

作者：

Webb, David John ^{[1
]}

机构：

[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland

来源：

JOURNAL OF HYPERTENSION | 2016年 / 34卷

关键词：

TRIAL;

D O I：

10.1097/01.hjh.0000500430.08107.56

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

BR 04-1

引用

收藏

页码：E198 / E198

页数：1

相关论文

共 6 条

[1] A Controlled Trial of Renal Denervation for Resistant Hypertension [J].

Bhatt, Deepak L. ;

Kandzari, David E. ;

O'Neill, William W. ;

D'Agostino, Ralph ;

Flack, John M. ;

Katzen, Barry T. ;

Leon, Martin B. ;

Liu, Minglei ;

Mauri, Laura ;

Negoita, Manuela ;

Cohen, Sidney A. ;

Oparil, Suzanne ;

Rocha-Singh, Krishna ;

Townsend, Raymond R. ;

Bakris, George L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) :1393-1401

[2] Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].

Calhoun, David A. ;

Jones, Daniel ;

Textor, Stephen ;

Goff, David C. ;

Murphy, Timothy P. ;

Toto, Robert D. ;

White, Anthony ;

Cushman, William C. ;

White, William ;

Sica, Domenic ;

Ferdinand, Keith ;

Giles, Thomas D. ;

Falkner, Bonita ;

Carey, Robert M. .

HYPERTENSION, 2008, 51 (06) :1403-1419

[3] Endothelin [J].

Davenport, Anthony P. ;

Hyndman, Kelly A. ;

Dhaun, Neeraj ;

Southan, Christopher ;

Kohan, Donald E. ;

Pollock, Jennifer S. ;

Pollock, David M. ;

Webb, David J. ;

Maguire, Janet J. .

PHARMACOLOGICAL REVIEWS, 2016, 68 (02) :357-418

[4] A Randomized Trial of Intensive versus Standard Blood-Pressure Control [J].

Wright, Jackson T., Jr. ;

Williamson, Jeff D. ;

Whelton, Paul K. ;

Snyder, Joni K. ;

Sink, Kaycee M. ;

Rocco, Michael V. ;

Reboussin, David M. ;

Rahman, Mahboob ;

Oparil, Suzanne ;

Lewis, Cora E. ;

Kimmel, Paul L. ;

Johnson, Karen C. ;

Goff, David C., Jr. ;

Fine, Lawrence J. ;

Cutler, Jeffrey A. ;

Cushman, William C. ;

Cheung, Alfred K. ;

Ambrosius, Walter T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2103-2116

[5] A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial [J].

Weber, Michael A. ;

Black, Henry ;

Bakris, George ;

Krum, Henry ;

Linas, Stuart ;

Weiss, Robert ;

Linseman, Jennifer V. ;

Wiens, Brian L. ;

Warren, Marshelle S. ;

Lindholm, Lars H. .

LANCET, 2009, 374 (9699) :1423-1431

[6] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial [J].

Williams, Bryan ;

MacDonald, Thomas M. ;

Morant, Steve ;

Webb, David J. ;

Sever, Peter ;

McInnes, Gordon ;

Ford, Ian ;

Cruickshank, J. Kennedy ;

Caulfield, Mark J. ;

Salsbury, Jackie ;

Mackenzie, Isla ;

Padmanabhan, Sandosh ;

Brown, Morris J. .

LANCET, 2015, 386 (10008) :2059-2068